Stryker vs. Zimmer Biomet vs. J&J in Q4: How 3 orthopedic companies compare

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter financial results for 2024 and data on their spine orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $6.4 billion (+10.7%)

Orthopedics: $2.5 billion (10.8%)

Hips: $463 million (+11.6%)

Knees: $687 million (+9%)

Spine: $186 million (+3.2%)

Net earnings: $500 million 

Zimmer Biomet

Total sales: $2 billion (+4.3%)

Hips: $520 million (+3%)

Knees: $839.2 million (+5.1%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $489 million (+8%)

Net earnings: $239.4 million

Johnson & Johnson

Total sales: $22.5 billion (+5.3%)

Orthopedic: $2.3 billion (+2.1%)

Spine, sports and other: $735 million (-0.9%)

Hips: $418 million (+5.2%)

Knees: $398 million (3.2%)

Net earnings: $3.4 billion

Advertisement

Next Up in Spinal Tech

Advertisement